Related Experiment Videos
Miliary brain metastases presenting as rapidly progressive dementia
Eloy Rivas1, Joaquin Sanchez-Herrero, Miguel Alonso
1Department of Pathology and Neuropathology, Meixoeiro Hospital, Vigo, Spain.
Summary
A rare case of rapidly progressive dementia (RPD) was caused by widespread cancer metastasis, not typical neurodegenerative diseases. This highlights the importance of considering cancer in RPD differential diagnoses.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Rapidly progressive dementia (RPD) presents a diagnostic challenge, often mimicking neurodegenerative conditions like dementia with Lewy bodies or Creutzfeldt-Jakob disease (CJD).
- The sudden onset of neurological symptoms post-surgery necessitates a broad differential diagnosis, including rare causes.
- Metastatic cancer can present with diverse neurological symptoms, including cognitive decline.
Observation:
- A 79-year-old woman developed RPD with severe memory loss, visual hallucinations, and extrapyramidal signs after hip surgery.
- Neurological deterioration progressed to akinetic mutism over five months, with seizures appearing terminally.
- Initial investigations, including MRI and CSF analysis, were inconclusive for common causes of RPD.
Findings:
- Neuropathological examination revealed extensive miliary metastatic adenocarcinoma, likely of pulmonary origin, despite no known primary tumor.
- Alzheimer's disease histopathological changes were noted, but Lewy bodies and PrP deposits were absent.
- The clinical presentation suggested a possible link between a pathological fracture, microembolic dissemination, and the sudden onset of dementia.
Implications:
- Metastatic cancer, particularly from an unknown primary, should be considered in the differential diagnosis of RPD, especially with sudden onset post-trauma or surgery.
- This case underscores the critical role of post-mortem neuropathological examination in identifying rare causes of dementia.
- Understanding such rare presentations can improve diagnostic accuracy and potentially guide future therapeutic strategies for dementia.